Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
117M
-
Shares change
-
-5.36M
-
Total reported value, excl. options
-
$1.78B
-
Value change
-
-$138M
-
Put/Call ratio
-
0.86
-
Number of buys
-
99
-
Number of sells
-
-102
-
Price
-
$15.27
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q2 2018
251 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q2 2018.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117M shares
of 170M outstanding shares and own 68.71% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (27.2M shares), FMR LLC (18.7M shares), BlackRock Inc. (9.74M shares), VANGUARD GROUP INC (8.67M shares), STATE STREET CORP (5.83M shares), OppenheimerFunds, Inc. (4.46M shares), ORBIMED ADVISORS LLC (4.28M shares), JANUS HENDERSON GROUP PLC (3.45M shares), Point72 Asset Management, L.P. (3.09M shares), and FIRST TRUST ADVISORS LP (2.6M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.